The China diabetes market size reached US$ 4.7 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 9.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2023-2032.
China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world.
The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.
China’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.
Historical, current and future prevalence of type-1 and type-2 diabetes in China
Historical, current and future prevalence of diabetes in the urban and rural regions in China
Historical, current and future prevalence of diabetes among males and females in China
Historical, current and future prevalence of diabetes among various age groups in China
Historical, current and future diagnosis rates for diabetes in China
Historical, current and future drug treatment rates for diabetes in China
Performance of key classes
Performance of key players
Market outlook
Performance of key classes
Performance of key players
Market outlook
Market Segmentation
Key players
Market outlook
China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world.
The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.
China’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.
What this Report Achieves:
Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in ChinaHistorical, current and future prevalence of type-1 and type-2 diabetes in China
Historical, current and future prevalence of diabetes in the urban and rural regions in China
Historical, current and future prevalence of diabetes among males and females in China
Historical, current and future prevalence of diabetes among various age groups in China
Historical, current and future diagnosis rates for diabetes in China
Historical, current and future drug treatment rates for diabetes in China
Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in ChinaPerformance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in ChinaPerformance of key classes
Performance of key players
Market outlook
Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:
Focus of the Analysis:
Performance of the diabetes diagnostics market in ChinaMarket Segmentation
Key players
Market outlook
Table of Contents
1 Preface3 Executive Summary
2 Scope and Methodology
4 Introduction
5 Diabetes Disease Overview
6 China Diabetes Epidemiology
7 China Diabetes Market
8 Competitive Landscape
List of Figures
List of Tables
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 131 |
| Published | July 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 4.7 Billion |
| Forecasted Market Value ( USD | $ 9.3 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | China |
